This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sanofi. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Marie-Claire Philippo-Orts: A Pioneer in Antithrombotic Research
Introduction
Marie-Claire Philippo-Orts is a notable inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. Her innovative work focuses on antithrombotic agents, which play a crucial role in preventing blood clots.
Latest Patents
Marie-Claire holds a patent for “Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application.” This invention relates to new sulphonylaminopyrrolidinone compounds that exhibit antithrombotic activity by inhibiting blood clotting factors IXa and/or Xa. The patent outlines both the processes for their preparation and their potential use as medical drugs.
Career Highlights
Marie-Claire is currently affiliated with Sanofi, a leading global biopharmaceutical company. Throughout her career, she has shown a commitment to advancing medical science, and her innovative approach has led to meaningful advancements in treating and preventing thrombotic disorders.
Collaborations
In her research endeavors, Marie-Claire collaborates with talented coworkers such as Nathalie Alet and Jean-Michel Altenburger. Their combined expertise has fostered a productive environment for innovation and discovery within the company.
Conclusion
Marie-Claire Philippo-Orts stands out as an inspiring inventor in the field of antithrombotic research. Her groundbreaking patent work at Sanofi underscores her dedication to improving healthcare outcomes. As innovations continue to emerge from her efforts, the impact of her work will undoubtedly be felt in the medical community for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
